-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
IGM Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
- IGM Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$51.4M, a 24.7% increase year-over-year.
- IGM Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$237M, a 4.54% increase year-over-year.
- IGM Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$263M, a 15.6% decline from 2022.
- IGM Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$228M, a 37.9% decline from 2021.
- IGM Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$165M, a 98.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)